Client News
Filter by:
- Nov 13 2023 Ispire Technology Inc. Schedules Fiscal First Quarter 2024 Earnings Conference Call
- Nov 13 2023 Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
- Nov 10 2023 FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma
- Nov 9 2023 Aspire North America, LLC Enters Five-Year Exclusive Manufacturing and Global Distribution Agreement with Hempacco Co., Inc.
- Nov 9 2023 Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
- Nov 9 2023 Sonim Announces Availability of PTT-Centric Phone XP5plus at Southern Linc
- Nov 8 2023 Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
- Nov 7 2023 Valero Energy Corporation Declares Regular Cash Dividend on Common Stock
- Nov 7 2023 MAIA Biotechnology Reports Third Quarter 2023 Financial Results and Highlights Recent Development Progress for Anticancer Asset THIO
- Nov 7 2023 Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results